Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation.

J Clin Med · 2023 · PMC10419906 · PMID 37568318

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Clazakizumab treatment showed a trend toward the stabilization of eGFR and reductions in DSA titers and graft inflammation [ 33 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.